These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 34215997)
1. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method. Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Schwendeman SP Drug Deliv Transl Res; 2022 Mar; 12(3):695-707. PubMed ID: 34215997 [TBL] [Abstract][Full Text] [Related]
2. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method. Beig A; Ackermann R; Wang Y; Schutzman R; Schwendeman SP Int J Pharm; 2022 Aug; 624():121842. PubMed ID: 35609832 [TBL] [Abstract][Full Text] [Related]
3. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres. Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463 [TBL] [Abstract][Full Text] [Related]
4. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release. Liang D; Frank S; Schwendeman SP Drug Deliv Transl Res; 2024 Mar; 14(3):696-704. PubMed ID: 38038895 [TBL] [Abstract][Full Text] [Related]
5. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide. Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448 [TBL] [Abstract][Full Text] [Related]
6. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres. Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173 [TBL] [Abstract][Full Text] [Related]
7. In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporation. Chandrashekar A; Beig A; Wang Y; Schwendeman SP Int J Pharm; 2023 Aug; 643():123213. PubMed ID: 37423376 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres. Wang J; Wang BM; Schwendeman SP Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856 [TBL] [Abstract][Full Text] [Related]
9. Sustained-release delivery of octreotide from biodegradable polymeric microspheres. Rhee YS; Sohn M; Woo BH; Thanoo BC; DeLuca PP; Mansour HM AAPS PharmSciTech; 2011 Dec; 12(4):1293-301. PubMed ID: 21948321 [TBL] [Abstract][Full Text] [Related]
10. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying. Shi NQ; Zhou J; Walker J; Li L; Hong JKY; Olsen KF; Tang J; Ackermann R; Wang Y; Qin B; Schwendeman A; Schwendeman SP J Control Release; 2020 May; 321():756-772. PubMed ID: 31935481 [TBL] [Abstract][Full Text] [Related]
11. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions. Murty SB; Goodman J; Thanoo BC; DeLuca PP AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545 [TBL] [Abstract][Full Text] [Related]
12. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. Witschi C; Doelker E J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres. Wang J; Wang BM; Schwendeman SP J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744 [TBL] [Abstract][Full Text] [Related]
14. Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment. Wang S; Downing G; Olsen KF; Sawyer TK; Cone RD; Schwendeman SP J Control Release; 2023 Dec; 364():589-600. PubMed ID: 37678438 [TBL] [Abstract][Full Text] [Related]
15. Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release. Vaishya RD; Mandal A; Patel S; Mitra AK Int J Pharm; 2015 Dec; 496(2):676-88. PubMed ID: 26561725 [TBL] [Abstract][Full Text] [Related]
16. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents. Wang FJ; Wang CH J Control Release; 2002 Jun; 81(3):263-80. PubMed ID: 12044566 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method. Cui F; Cun D; Tao A; Yang M; Shi K; Zhao M; Guan Y J Control Release; 2005 Oct; 107(2):310-9. PubMed ID: 16255081 [TBL] [Abstract][Full Text] [Related]
18. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends. Wang T; Xue P; Wang A; Yin M; Han J; Tang S; Liang R Eur J Pharm Sci; 2019 Oct; 138():104990. PubMed ID: 31302216 [TBL] [Abstract][Full Text] [Related]
19. A biomimetic approach to active self-microencapsulation of proteins in PLGA. Shah RB; Schwendeman SP J Control Release; 2014 Dec; 196():60-70. PubMed ID: 25219750 [TBL] [Abstract][Full Text] [Related]
20. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Blanco D; Alonso MJ Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]